ACCISS STUDY | TOOLS
Monitoring Access to Insulin
A country-level tool for tracking the price, availability and affordability of insulin, delivery devices and self-monitoring supplies — and for turning that evidence into policy change.
Country dashboards
National data collected with in-country partners – results from facilities and household monitoring
Kyrgyzstan
Mali
Peru
Tanzania
View dashboard →
Compare data across all countries
https://youtu.be/cwQ_Tf2awKk?si=Jj3TrVQDFoj0IqjY
LATEST FILM
Beyond Access to Insulin: Two Approaches to Care
Insulin alone does not manage type 1 diabetes. This film follows what happens when health systems treat care as more than a supply problem.
Our evidence base
More than a decade of research on insulin markets, prices, patents, procurement and health system response — over one hundred publications, all open access. Check out the latest here.
Browse the full A–Z
2026
ACCISS Study Focus Groups: Cross Country Synthesis
Focus groups aimed to better understand the systemic challenges and support needs of people living with type 1 diabetes.
Read more
2026
Moving forward on access to glucose self-monitoring technologies
Analyzing global barriers and highlighting strategic pathways to ensure equitable access to continuous and self-monitoring glucose systems.
Read the report
2025
Government procurement of insulin: case studies in 11 LMICs
A comprehensive review looking closely at public sector procurement mechanisms, tender efficiencies, and resulting pricing of human and analogue insulins.